1. HBV Seroprotection and Anamnestic Response to Booster Vaccination in Pediatric Cancer Survivors
- Author
-
Chanchai Traivaree, Detchvijitr Suwanpakdee, Wattanee Taweesith, and Piya Rujkijyanont
- Subjects
medicine.disease_cause ,immunization ,Pediatrics ,complex mixtures ,RJ1-570 ,03 medical and health sciences ,protective immunity ,0302 clinical medicine ,030225 pediatrics ,Global health ,medicine ,030212 general & internal medicine ,Hepatitis B virus ,business.industry ,Hepatitis B ,medicine.disease ,Pediatric cancer ,Vaccination ,pediatric cancer survivors ,Immunization ,Pediatric Oncology ,Pediatrics, Perinatology and Child Health ,Immunology ,Original Article ,Anamnestic response ,Complication ,business ,hepatitis B virus ,anamnestic response - Abstract
Hepatitis B is a major global health concern and can be prevented in the era of vaccination. Impaired immunological memory to primary immunization is a common chemotherapy-related complication among cancer survivors. The study aimed to determine protective immunity against hepatitis B virus (HBV) and anamnestic response to booster vaccination. In all, 107 pediatric cancer survivors previously immunized with primary hepatitis B vaccination were enrolled. A hepatitis B booster dose was administered to those with suboptimal seroprotection (anti-HBs
- Published
- 2021